Angiotensin-converting enzyme in non-neoplastic kidney diseases

Kidney International

Volumn 56, Issue 4, 1999, Pages 1442-1454

  Metzger, Roman ^a   Bohle, Rainer M ^b   Pauls, Katharina ^c   Eichner, Gerrit ^d   Alhenc Gelas, François ^a   Danilov, Sergei M ^b   Franke, Folker E ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c INSERM   (France)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

ACE; CD143; Endothelium; Interstitial fibrosis; Interstitium; Kidney; Vascular system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; KIDNEY PARENCHYMA; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0001595625     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00660.x     Document Type: Conference Paper

References (74)

1. SOFFER RL: Angiotensin-converting enzyme and the regulation of vasoactive peptides. Annii Rev Biochem 45:73-94, 1976
2. SKIDGEL R A, ERDOS EG: Biochemistry of angiotensin-I converting enzyme, in Renin Angiotensin System, edited by ROBERTSON JIS, NICHOLS MG, London, Gower Medical Publishers, 1993, pp 10.1-10.10
3. RYAN US, RYAN JW, WIIITAKER C, Cinu A: Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 8:125-145, 1976
4. CALDWELL PR, SEEGAL BC, Hsu KC, DAS M, SOFFER RL: Angiotensin-converting enzyme: Vascular endothelial localization. Science 191:1050-1051, 1976
5. FALKENHAHN M, FRANKE F, BOHLE RM, Ziiu YC, STAUSS HM, BACHMANN S, DANILOV S, UNGER T: Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25:219-226, 1995
6. SUN Y, WEBER KT: Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. / Lab Clin Med 127:94-101, 1996
7. Deleted in proof
8. Deleted in proof
9. DIET F, PRATT RE, BERRY GJ, MOMOSE N, GIBBONS GH, DZAU VJ: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767, 1996
10. TAKADA Y, HIWADA K, UNNO M, KOKUBU T: Immunological localization of angiotensin cons-erting enzyme at ultrastructural level in the human lung and kidney. Biomed Res 3:169-174, 1982
11. DEFENDINI R, ZIMMERMAN EA, WEARE JA, ALHENC-GELAS F, ERDOS EG: Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology 37:32-40, 1983
12. ALHENC-GELAS F, BAUSSANT T, HUBERT C, SOUBRIER F, CORVOL P: The angiotensin converting enzyme in the kidney. J Hypertens 7(Suppl):S9-S13, 1989
13. BRUNEVAL P, HINGLAIS N, ALHENC-ûELAS F, TRICOTTET V, CORVOL P, MENARD J, CAMILLERI JP, BARIETY J: Angiotensin I converting enzyme in human intestine and kidney: Ultrastructural immunohistochemical localization. Histocliemistry 85:73-80, 1986
14. DANILOV SM, FAERMAN AI, PRINTSEVA OY, MARTYNOV AV, SAKHAROV IY, TRAKIIT IN: Immunohistochemical study of angiotensinconverting enzyme in human tissues using monoclonal antibodies. Histocliemistry 87:487-490, 1987
15. DANILOV SM, FRANKE FE, ERDOS EG: CD143 (angiotensin-converting enzyme) workshop panel report, in Leucocyte Typing VI, edited by KISHIMOTO T, KIKUTANI H, VON DEM BORNE AEG, GOYERT SM, MASON DY, MIYASAKA M, MORETTA L, OKUMURA K, SHAW S, SPRINGER TA, SUGAMURA K, ZOLA H, New York and London, Garland Publishing, 1997, pp 746-749
16. FRANKE FE, METZGER R, BOHLE RM, KERKMAN L, ALHENC-GELAS F, DANILOV SM: CD143 workshop: Angiotensin-I-converting enzyme (CD 143) on endothelial cells in normal and in pathological conditions, in Leucocyte Typing VI, edited by KISHIMOTO T, KIKUTANI H, VON DEM BORNE AEG, GOYERT SM, MASON DY, MIYASAKA
17. M, MORETTA L, OKUMURA K, SHAW S, SPRINGER TA, SUGAMURA K, ZOLA H, New York and London, Garland Publishing, 1997, pp 749-751
18. HALL ER, KATO J, ERDOS EG, ROBINSON CJ, OSIIIMA G: Angiotensin I-converting enzyme in the nephron. Life Sci 18:1299-1303, 1976
19. TAUGNER R, GANTEN D: The localization of converting enzyme in kidney vessels of the rat. Histochemistry 75:191-201, 1982
20. IKEMOTO F, SONG GB, TOMINAGA M, KANAYAMA Y, YAMAMOTO K: Angiotensin-converting enzyme in the rat kidney: Activity, distribution, and response to angiotensin-converting enzyme inhibitors. Nephron 55(Suppl 1):S3-S9, 1990
21. DANILOV S, JASPARD E, CIIURAKOVA T, TOWBIN H, SAVOIE F, WEI L, ALIIENC-GELAS F: Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies: Selective inhibition of the amino-terminal active site. J Dial Chem 269:2680626814, 1994
22. ROBINSON A, WHITE T, MASON D: MRC OX-43: A monoclonal antibody which reacts with all vascular endothelium in the rat except that of brain capillaries. Immunology 57:231-237, 1985
23. CORDELL JL, FALINI B, ERBER WN, GHOSH AK, ABDULAZIZ Z, MACüONALD S, PULFORD KA, STEIN H, MASON DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytocliem 32:219-229, 1984
24. FRANKE FE, SCHACHENMAYR W, OSBORN M, ALTMANNSBERGER M: Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am J Palliol 139:67-79,1991
25. ROTH J, SAREMASLANI P, WARHOL MJ, HEITZ PU: Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensification. Lab Invest 67:263-269, 1992
26. WENDELSCHAFER-CRABB G, ERLANDSEN SL, WALKER DH: Ultrastructural localization of viral antigens using the unlabeled antibody-enzyme method. J Histochem Cytocliem 24:517-526, 1976
27. LASCANO EF, BERRIA MI: PAP labeling enhancement by osmium tetroxide-potassium ferrocyanide treatment. J Histochem Cytocliem 36:697-699, 1988
28. ZEIHER AM, GOEBEL H, SCIIACHINGER V, IHLING C: Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91:941-947, 1995
29. HABERBOSCH W, BOULE RM, FRANKE FE, DANILOV S, ALIIENCGELAS F, BRAUN-DULLAEUS R, HöLSCHERMANN H, WAAS W, TILLMANNS H, GARDEMANN A: The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis 130:203-213, 1997
30. MACûREGOR DP, MURONE C, MENDELSOHN FA: The stability of angiotensin receptors and angiotensin converting enzyme in post mortem brain. Neitrochem Int 25:413-417, 1994
31. MARCHETTI J, ROSEAU S, ALIIENC-GELAS F: Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron. Kidney Int 31:744-751, 1987
32. SEIKALY MG, ARANT BS JR, SENEY FD JR: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J din Invest 86:1352-1357, 1990
33. BRAAM B, MITCHELL KD, Fox J, NAVAR LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol 264:F891-F898, 1993
34. SCHUSTER VL, KOKKO JP, JACOBSON HR: Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 73:507-515, 1984
35. Liu FY, COGAN MG: Angiotensin II stimulates early proximal bicarbonate absorption in the rat by decreasing cyclic adenosine monophosphate. J Clin Invest 84:83-91, 1989
36. BROWN GP, DOUGLAS JG: Angiotensin II-binding sites in rat and primate isolated renal tubular basolateral membranes. Endocrinology 112:2007-2014, 1983
37. CLAUSER E, CURNOW KM, DAVTES E, CONCHON S, TEUTSCH B, VIANELLO B, MONNOT C, CoRVOL P: Angiotensin II receptors: Pro-tein and gene structures, expression and potential pathological involvements. Eitr J Endocrinol 134:403-411, 1996
38. FEI YJ, KANAI Y, NUSSBERGER S, GANAPATHY V, LEIBACH FH, ROMERO MF, SINGII SK, BORON WF, HEDIGER MA: Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368:563-566, 1994
39. Liu W, LIANG R, RAMAMOORTIIY S, FEI YJ, GANAPATHY ME, HEDIGER MA, GANAPATHY V, LEIBACH FH: Molecular cloning of PEPT 2, a new member of the IWpeptide cotransporter family, from human kidney. Biocliim Biophys Acta 1235:461-466, 1995
40. BOLL M, HERGET M, WAGENER M, WEBER WM, MARKOVICII D, BIBER J, CLAUSS W, MURER H, DANIEL H: Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. Proc Nail Acad Sci USA 93:284-289, 1996
41. NUSSBERGER S, HEDIGER MA: How peptides cross biological membranes, (editorial) Exp Neplirol 3:211-218, 1995
42. LEIBACH FH, GANAPATHY V: Peptide transporters in the intestine and the kidney. Annu Rev Nulr 16:99-119, 1996
43. KATO I, TAKADA Y, NISHIMURA K, HIWADA K, KOKUBU T: Increased urinary excretion of angiotensin converting enzyme in patients with renal diseases. J Clin Chem din Biochem 20:473-476, 1982
44. HOSOJIMA H, MIYAUCHI E, MORIMOTO S: Urinary excretion of angiolensin-converting enzyme in N1DDM patients with nephropathy. Diabetes Care 12:580-582, 1989
45. PEDRAZA-CIIAVERRI J, CRUZ C, DEL SOCORRO-BLANCAS M, HERNANDEZ-PANDO R, IBARRA-RUBIO ME, LARRIVA-SAHD J, TAPIA E: Angiotensin I converting enzyme activity in uranyl nitrate induced acute renal failure in rats. Renal Fail 17:377-388, 1995
46. CIIEN X, CATRAVAS JD: Neutrophil-mediated endothelial angiotensin-converting enzyme dysfunction: Role of oxygen-derived free radicals. Am J Pliysiol 265:L243-L249, 1993.
47. KUMAR S, WEST DC, ACER A: Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation 36:57-70,1987
48. Kuzu I, BICKNELL R, FLETCHER CD, GATTER KC: Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 69:322-328, 1993
49. RISAU W: Differentiation of endothelium. FASEB J 9:926-933, 1995
50. SILVERSTEIN E, PERTSCHUK LP, FRIEDLAND J: Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci USA 76:6646-6648, 1979
51. TAKADA Y, HIWADA K, YOKOYAMA M, Ocm K, TAKEUCIII M, KOKUBU T: Angiotensin converting enzyme: A possible histologie indicator for human renal cell carcinoma. Gwicer 56:130-133,1985
52. CAMPBELL-BOSWELL M, ROBERTSON AL JR: Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Palhol 35:265-276, 1981
53. NAFTILAN AJ: The role of angiotensin II in vascular smooth muscle cell growth. J Cardiovasc Pharmacol 20(SuppI 1):S37-S40, 1992
54. WEBER H, WEBB ML, SERAFINO R, TAYLOR DS, MORELAND S, NORMAN J, MOLLOY CJ: Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: Evidence for common signaling mechanisms. Mol Endocrinol 8:148158, 1994
55. POWELL JS, CLOZEL JP, MULLER RK, KüHN H, HEFTI F, HOSANG M, BAUMGARTNER HR: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-188, 1989
56. RAKUGI H, WANG DS, DZAU VJ, PRATT RE: Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 90:449-455, 1994
57. WOLF G: Angiotensin as a renal growth promoting factor. Ailv Exp Med Biol 377:225-236, 1995
58. TuFRO-McREDDiE A, ROMAND LM, HARRIS JM, FERDER L, GOMEZ RA: Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-F115, 1995
59. HILOERS KF, REDDI V, KREGE JH, SMITHIES O, GOMEZ A: Aberrant renal vascular morphology and renin expression in mutant mice lacking angiotensin-converting enzyme. Hypertension 29:216-221, 1997
60. ESTHER CR JR, HOWARD TE, MARINO EM, GODDARD JM, CAPECCIII MR, BERNSTEIN KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965, 1996
61. OKADA H, SUZUKI H, KANNO Y, IKENAGA H, SARUTA T: Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats. J Canliovasc Pharmacol 26:564-569, 1995
62. ROSENBERG ME, SMITH LJ, CORREA-ROTTER R, HOSTETTER TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410, 1994
63. ANDERSON S, JUNG FF, INGELFINGER JR: Renal rcnin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Pliysiol 265:F477-F4S6, 1993
64. MIZUIRI S, YOSIIIKAWA H, TANEGASHIMA M, MIYAGI M, KOBAYASIü M, SAKAI K, HAYASIII I, AIKAWA A, OIIARA T, HASEGAWA A: Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. Am J Kidney Dis 31:301-307, 1998
65. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE TT, HALLAB M, CAMBIEN F, PASSA P, ALIIENC GELAS F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
66. JARDINE AG, PADMANABHAN N, CONNELL JM: Angiotensin converting enzyme gene polymorphisms and renal disease. Curr Opin Nephrol Hypertens 7:259-264, 1998
67. ERLEY CM, HARRER U, KRAMER BK, RISLER T: Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor. Kidney Int 41:1297-1303, 1992
68. REMUZZI A, IMBERTI O, PUNTORIERI S, MALANCHINI B, MACCONI D, MAGKINI L, BERTANI T, REMUZZI G: Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats. Am J Pliysiol 267:F1034-F1044, 1994
69. PRAGA M, HERNANDEZ E, MONTOYO C, ANDRES A, RUILOPE LM, RoDicioJL: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20:240-248, 1992
70. LEWIS EJ, HUNSICKER LG, BAIN RP, ROIIDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. NEnglJ Med 329:1456-1462, 1993
71. RUILOPE LM: Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy. J Hypertens 13 (Suppl):S91-S93, 1995
72. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JF, MoTOLESE M, PONTICELLI C, RITZ E, ZucciiELLi P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: The Angiotensin-ConvertingEnzyme Inhibition in Progressive Renal Insufficiency Study Group. N EnglJ Med 334:939-945, 1996
73. THE GISEN GROUP: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857-1863, 1997 .
74. FINK L, SEEGER W, ERMERT L, HANZE J, STAHL U, GRIMMINGER F, KUMMER W, BOHLE RM: Real-time quantitative RT-PCR after laser-assisted cell picking. Nature Med 4:1329-1333, 1998